Clinical evaluation of the efficacy of dietary sulforaphane on lipid metabolism in postmenopausal women - Effect of sulforaphane on lipid metabolism

Department of Obstetrics and Gynecology, Nasu Red Cross Hospital0 个研究点目标入组 40 人开始时间: 2016年6月14日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•We will exclude outpatients 1) who show the abnormal value of blood lipids (TC:260 mg/dL or more, LDL-C:180 mg/dL or more, HDL-C: less than 30 mg/dL), and then are or will be undergoing treatment for abnormal lipid metabolism 2) who regularly use hormone preparations and hypolipidemic drug, and then are judged unsuitable for this study 3) with serious liver diseases in their life or suspected liver diseases 4) with serious diseases in their life and then judged unsuitable for this study 5) with serious diseases such as heart diseases, kidney diseases, organ damage and diabetes 6) with risk of allergy 7) who habitually consume higher amount of alcohol (> avg 60 g alcohol/day) 8) who participated in other clinical trials within 2 months 9) who are judged unsuitable for this study by principal investigator

发起方

Department of Obstetrics and Gynecology, Nasu Red Cross Hospital